Target intelligence / Profile preview

MicroRNA 4312 (MIR4312)

Target
MIR4312
Molecular classification
microRNA, Non-coding RNA
01

Overview

MicroRNA 4312 (MIR4312) is a short non-coding RNA molecule of approximately 20-24 nucleotides involved in the post-transcriptional regulation of gene expression in human cells[3]. MIR4312 is listed in the HGNC database (HGNC: 38376) and encoded at NCBI Gene ID 100422971, with alias hsa-mir-4312[3]. MicroRNAs such as MIR4312 are transcribed by RNA polymerase II, processed by the Drosha and Dicer enzymes, and finally incorporated into the RNA-induced silencing complex (RISC), where they regulate the stability and translation of specific target mRNAs through base-pairing interactions, often resulting in translational inhibition or mRNA destabilization[3][1][6][2][5][7]. There is no evidence that MIR4312 represents a direct therapeutic target (for example, it is not a receptor, enzyme, transporter, or transcription factor). Instead, it functions as part of the general microRNA network modulating gene expression, with possible indirect roles in diverse cellular processes and diseases[3][1][4][6][2][5][7]. Pathway, disease association, drug, biomarker, and safety concern data specific to MIR4312 were not found. As a member of the microRNA family, it may be involved in gene regulation pathways and could potentially act as a biomarker or therapeutic regulator if future research identifies disease-specific roles.

Other names
hsa-mir-4312MIR4312microRNA 4312
02

Biological functions

Post-transcriptional regulation of gene expressionmRNA degradationTranslational inhibition
03

Disease associations

Other (generic microRNA involvement in various diseases, no direct evidence for MIR4312 and a specific disease)

Beyond the preview

Go deeper on MicroRNA 4312 (MIR4312).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4312 (MIR4312).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call